FEATURED/ARCHIVES (20/05/24)
Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients with Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases · November 2012
Articles
NCBI>Primary Care Companion for CNS Disorders
Liver-Related Safety Assessment of Green Tea Extracts in Humans: A Systematic Review of Randomized Controlled Trials · May 2016
Articles
European Journal of Clinical Nutrition
Adverse Event Reports in Patients Taking Psychiatric Medication during Pregnancy from Spontaneous Reports in Japan and the United States: An Approach Using Latent Class Analysis · March 2020
Articles
BMC Psychiatry
Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays · July 2019
Articles
Pharmaceuticals
Safety Evaluation of High Bioavailability Curcumin in Healthy Japanese Adults: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Comparison Study · December 2023
Articles
Functional Foods in Health and Disease
Associations of Benzodiazepine with Adverse Prognosis in Heart Failure Patients with Insomnia · March 2020
Articles
Journal of the American Heart Association
Dosage, Effectiveness, and Safety of Sertraline Treatment for Posttraumatic Stress Disorder in a Japanese Clinical Setting: A Retrospective Study · December 2016
Articles
BMC Psychiatry
Efficacy and Tolerability of Topiramate-Augmentation Therapy for Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · December 2016
Articles
Neuropsychiatric Disease and Treatment
Clozapine Responders May Have Fewer Extrapyramidal Symptoms than Non-Responders: A Preliminary Report · April 2013
Articles
Clinical Neuropsychopharmacology and Therapeutics
Prevention of Antipsychotic-Induced Hyperglycaemia by Vitamin D: A Data Mining Prediction Followed by Experimental Exploration of the Molecular Mechanism · May 2016
Articles
Scientific Reports
Possible Association Between Moderate Intellectual Disability and Weight Gain in Valproic Acid-Treated Patients with Epilepsy · April 2015
Articles
Neuropsychiatric Disease and Treatment
Acute-Onset Type 1 Diabetes that Developed during the Administration of Olanzapine · February 2017
Articles
Internal Medicine
Metareview on Short-Term Effectiveness and Safety of Antidepressants for Depression: An Evidence-Based Approach to Inform Clinical Practice · September 2007
Articles
Canadian Journal of Psychiatry
Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review · May 2015
Articles
NCBI>Canadian Journal of Psychiatry
Influence of Antipsychotics on Functional Prognosis After Geriatric Hip Fracture · February 2019
Abstracts
Journal of Nutrition, Health and Aging
Hyperglycemic Adverse Events Following Antipsychotic Drug Administration in Spontaneous Adverse Event Reports · April 2015
Articles
Journal of Pharmaceutical Health Care and Sciences
Regular Follow-Up of Olanzapine Blood Levels and Impaired Glucose Tolerance in Olanzapine-Induced Diabetic Ketoacidosis: A Case Report · February 2014
Articles
Clinical Neuropsychopharmacology and Therapeutics
Domperidone Effective in Preventing Rivastigmine-Related Gastrointestinal Disturbances in Patients with Alzheimer’s Disease · September 2013
Articles
Neuropsychiatric Disease and Treatment
Efficacy and Safety of Vitamin K with Sorafenib Combination Treatment Against Hepatocellular Carcinoma: Open-Label, Randomized Phase II Study (Meetings-Events) · June 2017
Abstracts
American Society of Clinical Oncology